This is a Validated Antibody Database (VAD) review about human RNF40, based on 3 published articles (read how Labome selects the articles), using RNF40 antibody in all methods. It is aimed to help Labome visitors find the most suited RNF40 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
RNF40 synonym: BRE1B; RBP95; STARING; E3 ubiquitin-protein ligase BRE1B; 95 kDa retinoblastoma protein binding protein; 95 kDa retinoblastoma-associated protein; BRE1 E3 ubiquitin ligase homolog B; BRE1-B; RING-type E3 ubiquitin transferase BRE1B; Rb-associated protein; ring finger protein 40, E3 ubiquitin protein ligase
Bethyl
rabbit polyclonal |
| Bethyl RNF40 antibody (Bethyl Lab, A300-719A) was used in western blot on mouse samples (fig 1b). EMBO J (2015) ncbi |
Cell Signaling Technology
rabbit monoclonal (D2R2O) |
| In order to report that the RAP80-binding partner TRAIP regulates recruitment of the damage signaling machinery and promotes homologous recombination, Cell Signaling Technology RNF40 antibody (Cell Signaling, 12187) was used in western blot on human samples at 1:2000 (fig s11). Nat Commun (2016) ncbi |
rabbit monoclonal (D2R2O) |
| Cell Signaling Technology RNF40 antibody (Cell Signaling, 12187) was used in chromatin immunoprecipitation on mouse samples (fig 2i) and in immunoprecipitation on human samples (fig 2g). EMBO J (2015) ncbi |
Sigma-Aldrich
mouse monoclonal (KA7-27) |
| In order to study the epigenetic mechanisms by which SUPT6H regulates estrogen receptor activity, Sigma-Aldrich RNF40 antibody (Sigma, R9029) was used in immunoprecipitation on human samples (fig 3) and in western blot on human samples (fig 3, 5). Oncogene (2015) ncbi |
Articles Reviewed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
related gene review
questions and comments